FDA Authorizes Nitenpyram for New World Screwworm
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has issued an Emergency Use...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has issued an Emergency Use...
Indianapolis, Indiana, USA, August 8, 2026 Elanco Animal Health has received an Emergency Use Authorization (EUA) from the U.S....
OVERLAND PARK, Kan., May 19, 2026 Dechra has announced that the U.S. Food and Drug Administration (FDA) approved CosACTHen®...
Rahway, New Jersey, USA — February 25, 2026 The U.S. Food and Drug Administration (FDA) has approved NUMELVI™ (atinvicitinib...
PENSACOLA, Fla., Feb. 12, 2026 — The U.S. Food and Drug Administration has granted full approval to KBroVet (potassium...
Libourne, France — February 9, 2026: Ceva Animal Health, the world’s fifth-largest animal health company, has announced strategic leadership...
DULUTH, Ga., Feb. 5, 2026 — Boehringer Ingelheim Animal Health USA Inc. announced that the U.S. Food and Drug...
PARSIPPANY, N.J. — December 11, 2025 — Zoetis Inc., the world’s leading animal health company, announced that its Board...
